Steven D Brown

Summary

Affiliation: The Clinical Microbiology Institute
Country: USA

Publications

  1. pmc Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards
    Peter C Fuchs
    The Clinical Microbiology Institute, Wilsonville, Oregon 97070, USA
    Antimicrob Agents Chemother 46:398-401. 2002
  2. pmc National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study
    Ian A Critchley
    Replidyne, Inc, 1450 Infinite Drive, Louisville, CO 80027, USA
    Antimicrob Agents Chemother 51:4382-9. 2007
  3. pmc Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4
    Stephen G Jenkins
    Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, NY, USA
    Ann Clin Microbiol Antimicrob 7:1. 2008
  4. pmc Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges
    Steven D Brown
    The Clinical Microbiology Institute, Wilsonville, OR 97070, USA
    Antimicrob Agents Chemother 54:2063-9. 2010
  5. pmc Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains
    Steven D Brown
    Clinical Microbiology Institute, 9725 S W Commerce Circle, Suite A1, Wilsonville, OR 97070, USA
    J Clin Microbiol 43:5804-7. 2005
  6. pmc Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control
    Steven D Brown
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070, USA
    J Clin Microbiol 45:2173-9. 2007
  7. ncbi request reprint Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control
    Steven D Brown
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 55:944-9. 2005
  8. pmc Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains
    Steven D Brown
    Clinical Microbiology Institute, 9725 S W Commerce Circle Suite A1, Wilsonville, OR 97070, USA
    J Clin Microbiol 42:5877-80. 2004
  9. ncbi request reprint PROTEKT US: results from the second year of this longitudinal surveillance study of antimicrobial resistance among respiratory tract pathogens isolated from paediatric and adult patients in the USA. Introduction
    Steven D Brown
    Clinical Microbiology Institute, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 54:i5. 2004
  10. ncbi request reprint Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study
    Steven D Brown
    Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A1, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 54:i7-15. 2004

Collaborators

Detail Information

Publications28

  1. pmc Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards
    Peter C Fuchs
    The Clinical Microbiology Institute, Wilsonville, Oregon 97070, USA
    Antimicrob Agents Chemother 46:398-401. 2002
    ..e., 52 and 71%, respectively. We conclude that the 30-microg disk of these two drugs cannot be reliably used to test pneumococci...
  2. pmc National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study
    Ian A Critchley
    Replidyne, Inc, 1450 Infinite Drive, Louisville, CO 80027, USA
    Antimicrob Agents Chemother 51:4382-9. 2007
    ..5 mug/ml for S. pneumoniae, 1 mug/ml for H. influenzae, and 0.5 mug/ml for M. catarrhalis, suggesting that faropenem shows promise as a treatment option for respiratory infections caused by contemporary resistant phenotypes...
  3. pmc Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4
    Stephen G Jenkins
    Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, NY, USA
    Ann Clin Microbiol Antimicrob 7:1. 2008
    ..pneumoniae isolates from patients with community-acquired respiratory tract infections collected between Year 1 (2000-2001) and Year 4 (2003-2004) of PROTEKT US...
  4. pmc Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges
    Steven D Brown
    The Clinical Microbiology Institute, Wilsonville, OR 97070, USA
    Antimicrob Agents Chemother 54:2063-9. 2010
    ..In addition, MIC quality control ranges of torezolid were determined for three CLSI-recognized standard ATCC reference strains...
  5. pmc Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains
    Steven D Brown
    Clinical Microbiology Institute, 9725 S W Commerce Circle, Suite A1, Wilsonville, OR 97070, USA
    J Clin Microbiol 43:5804-7. 2005
    ....
  6. pmc Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control
    Steven D Brown
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070, USA
    J Clin Microbiol 45:2173-9. 2007
    ..03 to 0.12 microg/ml; S. pneumoniae ATCC 49619, 0.015 to 0.12 microg/ml and 23 to 29 mm; Haemophilus influenzae ATCC 49247, 0.06 to 0.5 microg/ml and 23 to 31 mm; and Neisseria gonorrhoeae ATCC 49226, 30 to 40 mm...
  7. ncbi request reprint Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control
    Steven D Brown
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 55:944-9. 2005
    ..To determine the spectrum of activity of doripenem and to propose tentative MIC and disc diffusion breakpoints...
  8. pmc Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains
    Steven D Brown
    Clinical Microbiology Institute, 9725 S W Commerce Circle Suite A1, Wilsonville, OR 97070, USA
    J Clin Microbiol 42:5877-80. 2004
    ..An eight-laboratory collaborative study generated the data needed to propose appropriate MIC control limits...
  9. ncbi request reprint PROTEKT US: results from the second year of this longitudinal surveillance study of antimicrobial resistance among respiratory tract pathogens isolated from paediatric and adult patients in the USA. Introduction
    Steven D Brown
    Clinical Microbiology Institute, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 54:i5. 2004
  10. ncbi request reprint Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study
    Steven D Brown
    Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A1, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 54:i7-15. 2004
    ....
  11. pmc Caspofungin disk diffusion breakpoints and quality control
    Steven D Brown
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070, USA
    J Clin Microbiol 46:1927-9. 2008
    ..3% for all categories. In addition, an eight-laboratory disk diffusion quality control (QC) study was performed, and QC ranges are proposed for the four QC strains recommended by the CLSI...
  12. pmc In vitro antimicrobial activity of a new cephalosporin, ceftaroline, and determination of quality control ranges for MIC testing
    Steven D Brown
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070, USA
    Antimicrob Agents Chemother 53:1271-4. 2009
    ..For the majority of species, the activity of ceftaroline was comparable or superior to that of ceftriaxone. MIC and/or disk diffusion quality control ranges of ceftaroline were determined for five standard ATCC reference strains...
  13. pmc Quality control limits for posaconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue
    S Brown
    The Clinical Microbiology Institute, Wilsonville, OR 97070, USA
    J Clin Microbiol 45:222-3. 2007
    ..parapsilosis ATCC 22019 (25 to 36 mm), C. tropicalis ATCC 750 (23 to 33 mm), and C. krusei ATCC 6258 (23 to 31 mm)...
  14. pmc Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study
    Steven D Brown
    Clinical Microbiology Institute, Wilsonville, Oregon, USA
    J Clin Microbiol 42:4980-7. 2004
    ..Almost 90% of the erythromycin-resistant isolates and approximately one-third of the levofloxacin-resistant isolates were multidrug resistant...
  15. ncbi request reprint In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime
    Peter C Fuchs
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 49:399-401. 2002
    ..0 mg/L. For strains resistant to the other antibiotics, susceptibility to telithromycin ranged from 98.6% for strains resistant to trimethoprim/sulfamethoxazole to 94.4% for strains resistant to cefotaxime...
  16. ncbi request reprint Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001-2002
    Steven D Brown
    Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A1, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 54:i23-9. 2004
    ..One of the main factors commonly associated with antibacterial resistance among Streptococcus pneumoniae is the age of the patient. The highest rates of resistance have often been reported among isolates from young children...
  17. pmc Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007
    Maria M Traczewski
    Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A 1, Wilsonville, OR 97070, USA
    Antimicrob Agents Chemother 53:1735-8. 2009
    ..Tolerance to vancomycin and teicoplanin was observed in 6.1% and 18.8% of the strains, respectively. Tolerance to daptomycin was not observed...
  18. pmc Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue
    A Barry
    The Clinical Microbiology Institute, Wilsonville, Oregon 97070, USA
    J Clin Microbiol 41:3410-2. 2003
    ..tropicalis ATCC 750 (26 to 37 mm), and C. albicans ATCC 90028 (28 to 39 mm). C. krusei ATCC 6258 was not useful for this purpose...
  19. pmc Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent
    Maria M Traczewski
    The Clinical Microbiology Institute, Inc, Wilsonville, OR 97070, USA
    Antimicrob Agents Chemother 52:3863-7. 2008
    ..For beta-hemolytic streptococci, a susceptible-only MIC of <or=0.25 microg/ml with a corresponding disk diffusion value of >or=15 mm can be proposed for susceptible-only microbiological cutoffs...
  20. ncbi request reprint In vitro bactericidal activity of daptomycin against staphylococci
    Peter C Fuchs
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070, USA
    J Antimicrob Chemother 49:467-70. 2002
    ..Of the four drugs tested, daptomycin was bactericidal against the most strains and had the most rapid cidal activity...
  21. ncbi request reprint Broth medium for microdilution susceptibility tests of fluconazole and voriconazole
    A Barry
    The Clinical Microbiology Institute, 9725 S W Commerce Circle, Suite A1, Wilsonville, Oregon 97070, USA
    Eur J Clin Microbiol Infect Dis 21:407-10. 2002
  22. ncbi request reprint Benefit-risk assessment of telithromycin in the treatment of community-acquired pneumonia
    Steven D Brown
    Clinical Microbiology Institute, Wilsonville, Oregon 97070, USA
    Drug Saf 31:561-75. 2008
    ..Although serious and sometimes fatal events have occurred in patients receiving telithromycin therapy, current data indicate that telithromycin offers an acceptable benefit risk ratio in the treatment of mild to moderate CAP...
  23. ncbi request reprint Preparation of stock solutions of macrolide and ketolide compounds for antimicrobial susceptibility tests
    A Barry
    The Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A 1, Wilsonville, OR 97070, USA
    Clin Microbiol Infect 10:78-83. 2004
    ..It was concluded that the easiest approach was to dissolve each compound in water with a small volume (< 2.5 microL/mL) of glacial acetic acid added in a dropwise fashion, followed by further dilutions in deionised water...
  24. pmc Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates
    Laura A Jevitt
    Division of Healthcare Quality Promotion, G 08, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
    J Clin Microbiol 44:3098-104. 2006
    ..In 2005, daptomycin disks were voluntarily removed from the market by Cubist Pharmaceuticals. The disk diffusion breakpoints were subsequently removed from the CLSI M100 standard in 2006...
  25. pmc Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem
    Ian A Critchley
    Replidyne Inc, 1450 Infinite Drive, Louisville, CO 80027, USA
    Antimicrob Agents Chemother 52:2639-43. 2008
    ..5% of all isolates. The MIC(90) of faropenem against serotype 19A isolates was 1 mug/ml, compared to > or =8 microg/ml against amoxicillin/clavulanate, cefdinir, cefuroxime axetil, and azithromycin...
  26. pmc Quality control parameters for broth microdilution tests of anidulafungin
    Karen Krisher
    J Clin Microbiol 42:490. 2004
  27. ncbi request reprint Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001
    Charles W Stratton
    Clinical Microbiology Laboratory, Vanderbilt University School of Medicine, Vanderbilt University Hospital, Nashville, TN 37201, USA
    Clin Ther 26:522-30. 2004
    ....
  28. pmc Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance
    David J Farrell
    G R Micro Ltd, London, United Kingdom
    Emerg Infect Dis 11:851-8. 2005
    ..3% were CC271, with the highest prevalence seen in South Africa, South Korea, and the United States. This study confirms the increasing global emergence and rapidly increasing US prevalence of this multidrug-resistant pneumococcal clone...